- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This book explores the controversial relationship between physicians and the pharmaceutical industry, identifies the ethical tensions and controversies, and proposes numerous reforms both for medicine's own professional integrity and for effective public regulation of the industry.
Andere Kunden interessierten sich auch für
- Erich FrommMan for Himself19,99 €
- Wildes, S.J., Kevin WmOrganizational Ethics and Moral Integrity in Secular Societies81,99 €
- Wildes, S.J., Kevin WmOrganizational Ethics and Moral Integrity in Secular Societies81,99 €
- Vulnerabilities88,99 €
- Natasha H. WilliamsArtificial Intelligence and Healthcare81,99 €
- Allan J. JacobsAssigning Responsibility for Children¿s Health When Parents and Authorities Disagree: Whose Child?55,99 €
- Erik NordCost-Value Analysis in Health Care106,99 €
-
-
-
This book explores the controversial relationship between physicians and the pharmaceutical industry, identifies the ethical tensions and controversies, and proposes numerous reforms both for medicine's own professional integrity and for effective public regulation of the industry.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Explorations in Bioethics and the Medical Humanities
- Verlag: Globe Pequot Publishing Group Inc/Bloomsbury
- Seitenzahl: 382
- Erscheinungstermin: 9. November 2007
- Englisch
- Abmessung: 229mm x 152mm x 22mm
- Gewicht: 619g
- ISBN-13: 9780742552197
- ISBN-10: 0742552195
- Artikelnr.: 23353745
- Herstellerkennzeichnung
- Books on Demand GmbH
- In de Tarpen 42
- 22848 Norderstedt
- info@bod.de
- 040 53433511
- Explorations in Bioethics and the Medical Humanities
- Verlag: Globe Pequot Publishing Group Inc/Bloomsbury
- Seitenzahl: 382
- Erscheinungstermin: 9. November 2007
- Englisch
- Abmessung: 229mm x 152mm x 22mm
- Gewicht: 619g
- ISBN-13: 9780742552197
- ISBN-10: 0742552195
- Artikelnr.: 23353745
- Herstellerkennzeichnung
- Books on Demand GmbH
- In de Tarpen 42
- 22848 Norderstedt
- info@bod.de
- 040 53433511
Howard Brody is professor and director for the Institute for the Medical Humanities, University of Texas Medical Branch at Galveston. Prior to this appointment, Dr. Brody was University Distinguished Professor of family practice, and philosophy at Michigan State University, where he also sat on the faculty of the Center for Ethics and Humanities in the Life Sciences; he served as director of the Center from 1985-2000. Dr. Brody completed his residency in family practice at the University of Virginia Medical Center. He received his MD from the College of Human Medicine, Michigan State University, in 1976, and his PhD in Philosophy, also from Michigan State University, in 1977. He currently sits on the board of the American Society for Bioethics and the Humanities, and specializes in ethics and the doctor-patient relationship. He has authored five books, among them Stories of Sickness (2002) and The Placebo Response: How You Can Release the Body's Inner Pharmacy for Better Health (2000). For up-to-date news about the issues covered in Hooked, visit Dr. Brody's new blog.
Chapter 1 Introduction: The Tipping Point Part 2 I. Overview Chapter 3 1.
The Good, the Bad, and the Ugly: A Story of Two Medications Chapter 4 2. An
Ethical Framework Part 5 II. Specific Issues and Problems Chapter 6 3. The
Pharmaceutical Industry and the Free Market Chapter 7 4. Patents, Generic
Drugs, and Academic Science Chapter 8 5. Research and Profits Chapter 9 6.
Suppression of Research Data Chapter 10 7. The Quality of Pharmaceutical
Research Chapter 11 8. The Drug Rep: Historical Background Chapter 12 9.
The Drug Rep Today Chapter 13 10. The Influence of Drug Reps: What the Data
Show Chapter 14 11. Continuing Medical Education Chapter 15 12.
Professional Organizations and Journal Advertising Chapter 16 13. The
Industry and the Consumer Chapter 17 14. The FDA: From Patent Medicine to
AIDS Drugs Chapter 18 15. The FDA and the Industry, 1990-2004 Part 19 III.
Toward Solutions Chapter 20 16. Solutions: The Management and Divestment
Strategies Chapter 21 17. Solutions Requiring Enhanced Professionalism in
Medicine Chapter 22 18. Solutions Requiring Regulatory Reform Chapter 23
Epilogue: Industry Woes and Professional Opportunities
The Good, the Bad, and the Ugly: A Story of Two Medications Chapter 4 2. An
Ethical Framework Part 5 II. Specific Issues and Problems Chapter 6 3. The
Pharmaceutical Industry and the Free Market Chapter 7 4. Patents, Generic
Drugs, and Academic Science Chapter 8 5. Research and Profits Chapter 9 6.
Suppression of Research Data Chapter 10 7. The Quality of Pharmaceutical
Research Chapter 11 8. The Drug Rep: Historical Background Chapter 12 9.
The Drug Rep Today Chapter 13 10. The Influence of Drug Reps: What the Data
Show Chapter 14 11. Continuing Medical Education Chapter 15 12.
Professional Organizations and Journal Advertising Chapter 16 13. The
Industry and the Consumer Chapter 17 14. The FDA: From Patent Medicine to
AIDS Drugs Chapter 18 15. The FDA and the Industry, 1990-2004 Part 19 III.
Toward Solutions Chapter 20 16. Solutions: The Management and Divestment
Strategies Chapter 21 17. Solutions Requiring Enhanced Professionalism in
Medicine Chapter 22 18. Solutions Requiring Regulatory Reform Chapter 23
Epilogue: Industry Woes and Professional Opportunities
Chapter 1 Introduction: The Tipping Point Part 2 I. Overview Chapter 3 1.
The Good, the Bad, and the Ugly: A Story of Two Medications Chapter 4 2. An
Ethical Framework Part 5 II. Specific Issues and Problems Chapter 6 3. The
Pharmaceutical Industry and the Free Market Chapter 7 4. Patents, Generic
Drugs, and Academic Science Chapter 8 5. Research and Profits Chapter 9 6.
Suppression of Research Data Chapter 10 7. The Quality of Pharmaceutical
Research Chapter 11 8. The Drug Rep: Historical Background Chapter 12 9.
The Drug Rep Today Chapter 13 10. The Influence of Drug Reps: What the Data
Show Chapter 14 11. Continuing Medical Education Chapter 15 12.
Professional Organizations and Journal Advertising Chapter 16 13. The
Industry and the Consumer Chapter 17 14. The FDA: From Patent Medicine to
AIDS Drugs Chapter 18 15. The FDA and the Industry, 1990-2004 Part 19 III.
Toward Solutions Chapter 20 16. Solutions: The Management and Divestment
Strategies Chapter 21 17. Solutions Requiring Enhanced Professionalism in
Medicine Chapter 22 18. Solutions Requiring Regulatory Reform Chapter 23
Epilogue: Industry Woes and Professional Opportunities
The Good, the Bad, and the Ugly: A Story of Two Medications Chapter 4 2. An
Ethical Framework Part 5 II. Specific Issues and Problems Chapter 6 3. The
Pharmaceutical Industry and the Free Market Chapter 7 4. Patents, Generic
Drugs, and Academic Science Chapter 8 5. Research and Profits Chapter 9 6.
Suppression of Research Data Chapter 10 7. The Quality of Pharmaceutical
Research Chapter 11 8. The Drug Rep: Historical Background Chapter 12 9.
The Drug Rep Today Chapter 13 10. The Influence of Drug Reps: What the Data
Show Chapter 14 11. Continuing Medical Education Chapter 15 12.
Professional Organizations and Journal Advertising Chapter 16 13. The
Industry and the Consumer Chapter 17 14. The FDA: From Patent Medicine to
AIDS Drugs Chapter 18 15. The FDA and the Industry, 1990-2004 Part 19 III.
Toward Solutions Chapter 20 16. Solutions: The Management and Divestment
Strategies Chapter 21 17. Solutions Requiring Enhanced Professionalism in
Medicine Chapter 22 18. Solutions Requiring Regulatory Reform Chapter 23
Epilogue: Industry Woes and Professional Opportunities